Tislelizumab-related enteritis successfully treated with adalimumab: A case report

doi:10.12998/wjcc.v10.i28.10186

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2512)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

133

WORD

HTML

1290

Figures (1-4)

372

Sum=1838

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

200

Download

474

Sum=674

Oct 6, 2022 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Oct 6, 2022; 10(28): 10186-10192
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10186

Full Size Figure Download Figure

Figure 4 Treatment of tislelizumab-related enteritis.

Citation: Chen N, Qian MJ, Zhang RH, Gao QQ, He CC, Yao YK, Zhou JY, Zhou H. Tislelizumab-related enteritis successfully treated with adalimumab: A case report. World J Clin Cases 2022; 10(28): 10186-10192
URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10186.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10186